Researchers at the Washington University Tuberous Sclerosis Center conduct both laboratory and clinical research, with the goals of characterizing the clinical features of TSC, understanding the biological basis of the disease, and ultimately developing and testing novel treatments for patients with TSC.

Rensing photo Nicholas Rensing
Laboratory Research Supervisor
Laura Jansen, MD, PhD
PREVeNT Epilepsy Trial and Cannabidiol Clinical Trial
novak Olga Novak
Clinical Research Coordinator
Ashley Fasciola, RN, BSN
Nurse Research Coordinator
Robin Ryther, MD, PhD
EXIST3 Clinical Trial and Cannabidiol Clinical Trial
Sid Jain, MBBS, MD
Cannabidiol Clinical Trial
Bo Zhang, MD, PhD
Laboratory Senior Scientist